Compare ARDX & UAMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ARDX | UAMY |
|---|---|---|
| Founded | 2007 | 1968 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.3B |
| IPO Year | 2014 | 1997 |
| Metric | ARDX | UAMY |
|---|---|---|
| Price | $6.21 | $8.37 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 5 |
| Target Price | ★ $15.14 | $9.44 |
| AVG Volume (30 Days) | 3.0M | ★ 10.7M |
| Earning Date | 04-30-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $2,607,000.00 | ★ $39,257,708.00 |
| Revenue This Year | $37.75 | $219.89 |
| Revenue Next Year | $34.24 | $104.28 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 162.80 |
| 52 Week Low | $3.50 | $1.94 |
| 52 Week High | $8.40 | $19.71 |
| Indicator | ARDX | UAMY |
|---|---|---|
| Relative Strength Index (RSI) | 56.13 | 46.71 |
| Support Level | $5.49 | $7.92 |
| Resistance Level | $6.23 | $8.38 |
| Average True Range (ATR) | 0.24 | 0.79 |
| MACD | 0.10 | -0.07 |
| Stochastic Oscillator | 94.53 | 23.79 |
Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. Its products Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.
United States Antimony Corp is a fully integrated mining, transportation, milling, smelting, and selling company. It has two operating segments: antimony and zeolite. Its products and services include antimony; silver; gold; zeolite products; and storage, handling, & packaging services. The company's geographical segments are the United States, Canada, and Mexico, of which the vast majority of its revenue comes from the United States.